These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7194491)

  • 1. Inhibition of platelet thromboxane synthetase by L-1-tosylamido-2-phenylethyl chloromethyl ketone.
    Yahn DM; Feinstein MB
    Prostaglandins; 1981 Feb; 21(2):243-54. PubMed ID: 7194491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet thromboxane synthetase by sulfasalazine.
    Stenson WF; Lobos E
    Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
    Uotila P; Matintalo M
    Prostaglandins Leukot Med; 1984 Apr; 14(1):41-6. PubMed ID: 6427791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions.
    Needleman P; Bryan B; Wyche A; Bronson SD; Eakins K; Ferrendelli JA; Minkes M
    Prostaglandins; 1977 Nov; 14(5):897-907. PubMed ID: 594391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.
    Gorman RR; Bundy GL; Peterson DC; Sun FF; Miller OV; Fitzpatrick FA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4007-11. PubMed ID: 269449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the formation of thromboxane B2 (TxB2), 12L-hydroxy-5,8,10 heptadecatrienoic acid (HHT) and 12L-hydroxy-5,8,10,14 eicosatrienoic acid (HETE) from arachidonic acid and of the TxB2 :HHT, TxB2 :HETE and (TxB2 +HHT) :HETE ratio in human platelets. Possible use in diagnostic purposes.
    Vincent JE; Zijlstra FJ; van Vliet H
    Prostaglandins Med; 1980 Aug; 5(2):79-84. PubMed ID: 7413847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
    Anderson MW; Crutchley DJ; Tainer BE; Eling TE
    Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay.
    Hecker M; Haurand M; Ullrich V; Diczfalusy U; Hammarström S
    Arch Biochem Biophys; 1987 Apr; 254(1):124-35. PubMed ID: 3579292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism.
    Defreyn G; Machin SJ; Carreras LO; Dauden MV; Chamone DA; Vermylen J
    Br J Haematol; 1981 Sep; 49(1):29-41. PubMed ID: 6268139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective effects of two chloromethyl ketones on amino acid and phosphate uptake in rat liver and tumors.
    Lea MA; Koch MR
    J Natl Cancer Inst; 1979 Jan; 62(1):181-5. PubMed ID: 281572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of external calcium on the oxygenated metabolism of endogenous and exogenous arachidonic acid in platelets.
    Velardo B; Lagarde M
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1109-14. PubMed ID: 3927915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
    Ishikawa S; Manabe S; Wada O
    Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W; Patscheke H
    Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of macromolecular synthesis in tumors by L-1-tosylamido-2-phenylethyl chloromethyl ketone.
    Lea MA; Barra R; Koch MR; Hicks H; Daly C
    Biochem Biophys Res Commun; 1977 Mar; 75(2):519-24. PubMed ID: 192237
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of quercetin, 1-tosylamido-2-phenylethyl chloromethyl ketone, cytochalasin A and nordihydroguaiaretic acid on lysosomal enzyme secretion, arachidonic acid metabolism and Ca2+ fluxes in rabbit neutrophils.
    Showell HJ; Naccache PH; Walenga RW; Dalecki M; Feinstein MB; Sha'afi RI; Becker EL
    J Reticuloendothel Soc; 1981 Sep; 30(3):167-81. PubMed ID: 6793724
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.